J07BN Covid-19 vaccines vacuna contra la COVID-19 2019冠状病毒病疫苗 嚴重特殊傳染性肺炎疫苗 L4
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikidata · CC0 1.0 来源:维基数据 · CC0 1.0 來源:維基數據 · CC0 1.0
ATC level L4 · Search this class · Consumer categories
Active ingredients in this class
30 active ingredients 30 principios activos 30 个活性成分 30 個有效成分
The market codes after a status are the markets where that status is recorded (same codes as the product tables). An ingredient can be on sale in one market and withdrawn in another; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Tozinamerán
J07BN01activeSGdiscontinuedCA ESwithdrawnES - Raxtozinameran
J07BN01discontinuedCAunknownAU HK - Elasomeran
J07BN01discontinuedCAunknownAU - Sars-Cov-2 Recombinant Spike Protein
J07BN04activeCA SGdiscontinuedCA - *Sarscov2 S-Protein Mrna, 5'[M27,3'-Ogppp
J07BN01activeCA - Vacuna Anti Covid 19 (Pfizer/Biontech) Tozinamerán
J07BN01discontinuedESwithdrawnES - Chadox1-S [Recombinant]
J07BN02discontinuedCAwithdrawnCA - *Sarscov2 S-Protein Mrna, 5'
J07BN01activeCA - Vacuna Anti Covid 19 (Pfizer/Biontech) Arnm Para Xfg (Provisional)
J07BN01activeESdiscontinuedES - Vacuna Anti Covid 19 (Pfizer/Biontech) Bretovamerán
J07BN01discontinuedESwithdrawnES - Vacuna Anti Covid 19 (Pfizer/Biontech) Cemivamerán
J07BN01discontinuedESwithdrawnES - Vacuna Anti Covid 19 (Pfizer/Biontech) Raxtozinamerán
J07BN01discontinuedES - Vacuna Anti Covid 19 (Hipra) Meracovateína
J07BN04activeESdiscontinuedES - Vacuna Anti Covid 19 (Hipra) Recombinante Para Xfg.1.1 (Provisional)
J07BN04activeES - Vacuna Anti Covid 19 (Moderna) Arnm Para Xbb.1.5 (Provisional)
J07BN01discontinuedES - Vacuna Anti Covid 19 (Novavax) Proteína Recombinante De La Espícula De Sars Cov 2 (Omicron Jn.1)
J07BN04discontinuedES - Ad26.Cov2.S [Recombinant]
J07BN02discontinuedCA - *Sarscov2 S-Protein Ntd-Rbd Subdomains Mrna, 5'
J07BN01activeCA - Vacuna Anti Covid 19 (Astrazeneca) Recombinante (Chadox1 S)
J07BN02withdrawnES - Vacuna Anti Covid 19 (Hipra) Recombinante
J07BN04discontinuedES - Vacuna Anti Covid 19 (Janssen/J&J) Recombinante (Ad26)
J07BN02withdrawnES - Vacuna Anti Covid 19 (Moderna) Andusomerán
J07BN01withdrawnES - Vacuna Anti Covid 19 (Moderna) Arnm Para Lp.8.1 (Provisional)
J07BN01discontinuedES - Vacuna Anti Covid 19 (Moderna) Arnm Para Xfg (Provisional)
J07BN01discontinuedES - Vacuna Anti Covid 19 (Moderna) De Arnm
J07BN01withdrawnES - Vacuna Anti Covid 19 (Novavax) Proteína Recombinante De La Espícula De Sars Cov 2
J07BN04discontinuedES - Vacuna Anti Covid 19 (Novavax) Proteína Recombinante De La Espícula De Sars Cov 2 (Omicron Xbb.1.5)
J07BN04discontinuedES - Vacuna Anti Covid 19 Proteína Recombinante De La Espícula De Sars Cov 2 (Omicron Xfg)
J07BN04discontinuedES - Vacuna Anti Covid 19 (Sanofi) Recombinante
J07BN04withdrawnES - Virus-Like Particles
J07BN04discontinuedCA
By dosage form, across markets
An ATC class only groups medicines by similar pharmacology/chemistry — it does not mean they are interchangeable. A different ingredient, dosage form, release mechanism or strength is not interchangeable.
Only ingredients with a recorded ATC class are listed (6,009 of 12,637).
Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.
Notes & licences
Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.
Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.
ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.